Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

253

HTML

2529

Figures (1-5)

202

Tables (1-2)

172

Sum=3156

Aug 14, 2005 (publication date) through Nov 14, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Aug 14, 2005; 11(30): 4721-4726
Published online Aug 14, 2005. doi: 10.3748/wjg.v11.i30.4721

Full Size Figure Download Figure

Figure 5 EGFR immunostaining (A) and immunoreactivity (B) after PPI therapy (200×magnification).

Citation: Hritz I, Herszenyi L, Molnar B, Tulassay Z, Pronai L. Long-term omeprazole and esomeprazole treatment does not significantly increase gastric epithelial cell proliferation and epithelial growth factor receptor expression and has no effect on apoptosis and p53 expression. World J Gastroenterol 2005; 11(30): 4721-4726
URL: https://www.wjgnet.com/1007-9327/full/v11/i30/4721.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i30.4721